Psoriasiform Dermatitis After Initiation of Treatment with Dupilumab for Atopic Dermatitis

Dermatitis. 2019 May/Jun;30(3):234-236. doi: 10.1097/DER.0000000000000481.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Biological Products / administration & dosage
  • Biological Products / adverse effects*
  • Dermatitis, Atopic / etiology*
  • Dermatitis, Atopic / prevention & control
  • Female
  • Humans
  • Middle Aged
  • Patch Tests / methods
  • Psoriasis / chemically induced*
  • Psoriasis / prevention & control

Substances

  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • dupilumab